Back
Intellia Therapeutics Vs. NeuroMetrix Industry Stock Comparison
Sell
42
NTLA
Intellia Therapeutics
Last Price:
23.59
Seasonality Move:
31.89%
Sell
41
NURO
NeuroMetrix
Last Price:
4.35
Seasonality Move:
3.49%
Sell
42
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $23.60. The Score for NTLA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
NeuroMetrix (NURO)
is a Sell
Is NeuroMetrix a Buy, Sell or Hold?
- The current NeuroMetrix [NURO] share price is $4.30. The Score for NURO is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- NURO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $23.60
The current trend is relatively stagnant and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
NURO Stock Price Chart
What is NeuroMetrix's stock price today?
-
The NeuroMetrix share price today is $4.30
The current trend is moderately bullish and NURO is experiencing selling pressure, which indicates risk of future bearish movement.
NTLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.96 | Sell |
| Relative Strength Index (14 RSI): | 50.91 | Buy |
| Chaikin Money Flow: | -997353 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.3 - 25.1) | Buy |
| Bollinger Bands (100): | (23.93 - 30.15) | Sell |
NURO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 54.32 | Buy |
| Chaikin Money Flow: | -15604 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.7 - 4.42) | Buy |
| Bollinger Bands (100): | (3.18 - 4.08) | Buy |
NTLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.84 | Buy |
| 20-day SMA: | 22.64 | Buy |
| 50-day SMA: | 26.03 | Sell |
| 200-day SMA: | 30.07 | Sell |
| 8-day EMA: | 22.41 | Buy |
| 20-day EMA: | 22.91 | Buy |
| 50-day EMA: | 24.8 | Sell |
| 200-day EMA: | 30.24 | Sell |
NURO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.43 | Sell |
| 20-day SMA: | 4.09 | Buy |
| 50-day SMA: | 3.99 | Buy |
| 200-day SMA: | 4.48 | Sell |
| 8-day EMA: | 4.37 | Sell |
| 20-day EMA: | 4.21 | Buy |
| 50-day EMA: | 3.99 | Buy |
| 200-day EMA: | 5.38 | Sell |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.13 per share, and an increase next year of $0.01 per share.
NeuroMetrix Earnings Growth & NURO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Intellia Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NeuroMetrix Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||